Cresset Asset Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.45M | Buy |
29,500
+930
| +3% | +$203K | 0.03% | 318 |
|
|
2025
Q1 | $6.4M | Buy |
28,570
+1,022
| +4% | +$229K | 0.03% | 309 |
|
|
2024
Q4 | $9.02M | Sell |
27,548
-2,681
| -9% | -$878K | 0.04% | 236 |
|
|
2024
Q3 | $9.07M | Buy |
30,229
+435
| +1% | +$131K | 0.03% | 323 |
|
|
2024
Q2 | $9.81M | Buy |
29,794
+6,018
| +25% | +$1.98M | 0.04% | 279 |
|
|
2024
Q1 | $9.41M | Sell |
23,776
-4,361
| -15% | -$1.73M | 0.05% | 257 |
|
|
2023
Q4 | $9.91M | Buy |
28,137
+1,270
| +5% | +$447K | 0.06% | 210 |
|
|
2023
Q3 | $10.1M | Buy |
26,867
+569
| +2% | +$213K | 0.04% | 193 |
|
|
2023
Q2 | $10.1M | Buy |
+26,298
| New | +$10.1M | 0.01% | 181 |
|
|
2022
Q4 | – | Sell |
-1,333
| Closed | -$328K | – | 912 |
|
|
2022
Q3 | $328K | Buy |
+1,333
| New | +$328K | ﹤0.01% | 645 |
|
|
2022
Q2 | – | Sell |
-2,373
| Closed | -$974K | – | 1101 |
|
|
2022
Q1 | $974K | Sell |
2,373
-6,309
| -73% | -$2.59M | 0.01% | 418 |
|
|
2021
Q4 | $4.07M | Buy |
8,682
+3,161
| +57% | +$1.48M | 0.04% | 171 |
|
|
2021
Q3 | $2.34M | Buy |
5,521
+2,040
| +59% | +$866K | 0.03% | 202 |
|
|
2021
Q2 | $1.25M | Buy |
3,481
+1,345
| +63% | +$483K | 0.02% | 299 |
|
|
2021
Q1 | $602K | Buy |
+2,136
| New | +$602K | 0.01% | 427 |
|
|
2020
Q4 | – | Sell |
-773
| Closed | -$212K | – | 815 |
|
|
2020
Q3 | $212K | Sell |
773
-305
| -28% | -$83.6K | ﹤0.01% | 626 |
|
|
2020
Q2 | $245K | Buy |
+1,078
| New | +$245K | 0.01% | 537 |
|
|
2019
Q2 | – | Sell |
-1,051
| Closed | -$116K | – | 1728 |
|
|
2019
Q1 | $116K | Buy |
1,051
+116
| +12% | +$12.8K | ﹤0.01% | 512 |
|
|
2018
Q4 | $92K | Buy |
+935
| New | +$92K | 0.01% | 345 |
|